These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 6321367

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Enoxacin: clinical results in lower respiratory tract infections.
    Grassi C, Mangiarotti P, Dal Prà ML.
    J Chemother; 1989 Jul; 1(4 Suppl):790-2. PubMed ID: 16312641
    [No Abstract] [Full Text] [Related]

  • 47. [A randomized controlled clinical trial of sulperazone as compared with cefotaxime in the treatment of bacterial infections].
    Li J, Miao J, Hu W.
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):680-2. PubMed ID: 8731830
    [Abstract] [Full Text] [Related]

  • 48. [Antibacterial treatment in infective bronchopulmonary pathology with special regard to the mode of the use of a bactericide drug].
    Donno L, Buogo A.
    Clin Ter; 1974 Jun 15; 69(5):431-45. PubMed ID: 4848059
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Clinical experience with the use of a new cephalosporin (cefotaxime) in infectious bronchopulmonary pathology].
    Baldini EV, Bonucchi ME, Lodi SA, Rossi G.
    G Ital Chemioter; 1980 Jun 15; 27(2):57-68. PubMed ID: 6281114
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C, Li J, Hou J, Guo M, Zhang Y, Chen Y.
    Chin Med J (Engl); 2000 Nov 15; 113(11):1026-30. PubMed ID: 11776118
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Efficacy and safety of cefditoren pivoxil in treatment of respiratory infections, a clinical study].
    Li JT, Gao L, Xue F, Hao FL, Wang Q, Cai BQ, Gan CL, Liu YN, Yu BX, He LX, Hu BJ, Chen XH, Zheng JC, Yu YS, Lu FF, Liang DR, Cai YN, Kang J, Kong LF, Xiao ZL, Zheng JP, Liu J, Yang WX, Zhou J.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):391-4. PubMed ID: 12820915
    [Abstract] [Full Text] [Related]

  • 57. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U.
    Praxis (Bern 1994); 2001 May 23; 90(21):931-4. PubMed ID: 11441707
    [Abstract] [Full Text] [Related]

  • 58. [Pefloxacin in the treatment of lower respiratory tract infections].
    Dericoloso A, Tranchese D, Bianco A, Cuccurullo S, Moro RA, Micillo E.
    Arch Monaldi Mal Torace; 1990 May 23; 45(1):21-9. PubMed ID: 1669257
    [Abstract] [Full Text] [Related]

  • 59. [Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs].
    Caputi M, Guarino C, Cautiero V, Sorrentino L, Cione P, Cuccurullo S, Tarantino C.
    Arch Monaldi Mal Torace; 1990 May 23; 45(5):401-10. PubMed ID: 2152338
    [Abstract] [Full Text] [Related]

  • 60. Cefotaxime therapy of serious bacterial infection in adults.
    Mullaney DT, John JF.
    Antimicrob Agents Chemother; 1982 Mar 23; 21(3):421-5. PubMed ID: 6285810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.